Details
The complement system is an important effector that bridges the innate and adaptive immune systems. The third component of complement, C3, plays a central role in activating the complement system. Its processing by C3 convertase is the central reaction in both classical and alternative complement pathways. Human C3, composed of α and β chains, is cleaved into C3a and C3b by C3 convertase. C3b is composed of the α' chain and β chain. Factor I cleaves the α′ chain of C3b to 68 kDa and 43 kDa degradation products (iC3b). Inactive iC3b stops convertase amplification but acts as an opsonin via CR3/CR4. Factor I and CR1 further cleave iC3b into C3d, linking innate recognition to B-cell activation via CR2.
An anti-tag antibody is pre-coated onto the bottom of wells. After adding antigen or samples, Tagged-Capture antibody and HRP-conjugated detection antibody, a sandwich complex is formed in the solution. TMB acts as a HRP substrate, and the solution color will change from colorless to blue. A stop solution containing sulfuric acid turns the solution yellow. The color intensity is proportional to the quantity of bound protein, which is measurable at 450 nm with the correction wavelength set at 630 nm.
Intra-assay Precision (Precision within an assay) Three samples of known concentration were tested 8 times on one plate to assess intra-assay precision. Inter-assay Precision (Precision between assays) Three samples of known concentration were tested in 16 separate assays to assess inter-assay precision.
Intra-assay Precision
| Sample | n | Mean (ng/mL) | SD | CV% |
| 1 | 8 | 10.89 | 0.12 | 1.10 |
| 2 | 8 | 2.70 | 0.06 | 2.22 |
| 3 | 8 | 1.33 | 0.13 | 9.77 |
Inter-assay Precision
| Sample | n | Mean (ng/mL) | SD | CV% |
| 1 | 16 | 11.02 | 0.18 | 1.63 |
| 2 | 16 | 2.73 | 0.07 | 2.56 |
| 3 | 16 | 1.35 | 0.13 | 9.63 |
The recovery of human C3 spiked to three different levels throughout the range of the assay in various matrices was evaluated.
| Sample Type | Average% of Expected | Range (%) | |
| Human plasma | 1:1,600,000 | 105 | 100-110 |
| 1:3,200,000 | 99 | 89-106 | |
| Cell culture supernatant | 1:800 | 98 | 89-107 |
| 1:1,600 | 95 | 91-100 | |
| Saliva | 1:160 | 104 | 102-106 |
| 1:320 | 101 | 95-109 | |
| Human milk | 1:2,000 | 101 | 98-102 |
| 1:4,000 | 102 | 101-104 | |
| Human cerebrospinal fluid (CSF) | 1:3,200 | 102 | 96-109 |
| 1:6,400 | 104 | 99-110 |
To assess the linearity of the assay, samples were diluted with the appropriate Sample Diluent to produce samples with values within the dynamic range of the assay. (The human plasma was initially diluted 1:200,000. The cell culture supernatant was initially diluted 1:100. The saliva was initially diluted 1:20. The human milk was initially diluted 1:500. The human cerebrospinal fluid (CSF) was initially diluted 1:400.)
| Human plasma(Sample DiluentPT 4B1) | Cell culturesupernatant(Sample DiluentPT 4B1-ec) | Saliva(SampleDiluent PT 4B1-ec) | Human milk(Sample DiluentPT 4B1) | CSF(Sample Diluent4B1-ec) | ||
| 1:2 | Average% ofExpected | 100 | 100 | 100 | 100 | 100 |
| Range (%) | - | - | - | - | - | |
| 1:4 | Average% ofExpected | 102 | 91 | 97 | 101 | 104 |
| Range (%) | 99-104 | 90-92 | 95-98 | 101-102 | 96-111 | |
| 1:8 | Average% ofExpected | 103 | 91 | 98 | 103 | 101 |
| Range (%) | 103-104 | 88-94 | 97-99 | 101-105 | 94-107 | |
| 1:16 | Average% ofExpected | 109 | 91 | 99 | 107 | 99 |
| Range (%) | 109-110 | 73-109 | 98-100 | 105-108 | 97-101 |
This immunoassay is calibrated against a highly purified recombinant human C3 produced at Sunlong Medical™.
Ordering & shipping
Citations
Partial purchase records (0)
Leave a message
+86 0571 56623320
[email protected]
+86 18668110335

Scan Wechat Qrcode
